Author:
D’Errico Antonia,Vasuri Francesco,Bagni Alberto
Publisher
Springer International Publishing
Reference34 articles.
1. Lacaille F. Intestinal transplantation: where are we? Where are we going? Curr Opin Organ Transplant. 2012;17:248–9.
2. Ruiz P. How can pathologists help to diagnose late complications in small bowel and multivisceral transplantation? Curr Opin Organ Transplant. 2012;17:273–4. Many reports suggest that MVTx plays a protective role against both acute cellular rejection (ACR) and chronic rejection (CR) compared with ITx, with a substantial decreasing of rejection disease.
3. Takahashi H, Kato T, Delacruz V, Nishida S, Selvaggi G, Weppler D, Island E, Moon JI, Levi DM, Tzakis AG, Ruiz P. Analysis of acute and chronic rejection in multiple organ allografts from retransplantation and autopsy cases of multivisceral transplantation. Transplantation. 2008;85:1610–6.
4. Tzakis AG, Kato T, Levi DM, Defaria W, Selvaggi G, Weppler D, Nishida S, Moon J, Madariaga JR, David AI, Gaynor JJ, Thompson J, Hernandez E, Martinez E, Cantwell GP, Augenstein JS, Gyamfi A, Pretto EA, Dowdy L, Tryphonopoulos P, Ruiz P. 100 multivisceral transplants at a single center. Ann Surg. 2005;242:480–90.
5. Lee RG, Nakamura K, Tsamandas AC, Abu-Elmagd K, Furukawa H, Huston WR, Reyes J, Tabasco-Minguillan JS, Todo S, Demetris AJ. Pathology of human intestinal transplantation. Gastroenterology. 1996;110:1820–34.